Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2005
12/07/2005EP1601251A2 Compounds for the treatment of metabolic disorders
12/07/2005EP1525198B1 Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof
12/07/2005EP1496917B1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
12/07/2005EP1427297B1 Composition for reducing appetite in mammals comprising procyanidin
12/07/2005EP1379528A4 Pyrazolopyrimidines as therapeutic agents
12/07/2005EP1353904B1 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
12/07/2005EP1307449B1 1,4-dihydropyridines as bradykinin antagonists
12/07/2005EP1303269B1 Use of 3-substituted oxindole derivatives as kcnq potassium channel modulators
12/07/2005EP1294711B1 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases
12/07/2005EP1272059B1 Method of producing oily suspensions of water-soluble vitamins
12/07/2005EP1270584B1 Glucopyranosyloxy benzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives
12/07/2005EP1217001B1 Quinuclidine compounds and drugs containing the same as the active ingredient
12/07/2005EP1117412B1 Compositions containing diphosphonic acids
12/07/2005EP1077928B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP1077927B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP0981523B1 Cyclic ether vitamin d3 compounds, 1alpha (oh) 3-epi-vitamin d3 compounds and uses thereof
12/07/2005CN1705654A Methods for treating depression and other cns disorders using enantiomerically enriched desmethyl-and didesmethyl-metabolites of citalopram
12/07/2005CN1705648A Alpha-phenyl acetanilide derivatives having an ACAT inhibiting activity and the therapeutic application thereof
12/07/2005CN1705647A Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/07/2005CN1705478A Novel compounds, pharmaceutical compositions containing same, and methods of use for same
12/07/2005CN1705476A Enhancement of alcohol metabolism
12/07/2005CN1704404A Tricyclic protein kinase inhibitors
12/07/2005CN1230434C Indazolyl-substituted pyrroline compounds as kinase inhibitor
12/07/2005CN1230202C External coated chewing gum products
12/07/2005CN1230191C Health care combination of propolis for reducing blood sugar and fat as well as method for mfg. its capsule
12/07/2005CN1230190C Medicine for treating diabetes
12/07/2005CN1230173C Preventives and remedies for complications of diabetes
12/07/2005CN1230171C Treating diabetes by thiazolidine-diketo and dimethylbiguanide
12/07/2005CN1230162C Pharmaceutical composition for modified release of an insulin sensitizing agent and another antidiabetic agent
12/07/2005CN1230158C Mixture of primary fatty acids obtained from sugar can wax and pharmaceutical use thereof
12/06/2005US6972340 For therapy of diabetes, obesity, autoimmune disorders, acute and chronic inflammatory disorders, osteoporosis, cancer, malignant disorders
12/06/2005US6972296 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines
12/06/2005US6972295 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
12/06/2005US6972283 Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof
12/06/2005US6972194 culturing cells in envelopes comprising acrylic amide homopolymers, for use in immunization against tumor cells and prophylaxis of diabetes; vaccines
12/06/2005US6972171 mixing polynucleotides with folic acid, hormones, peptides, glycoproteins, lipids or phosphatides to form nucleotides used as drugs; genetic engineering; gene expression
12/06/2005CA2354606C Azabicycloalkane derivatives and therapeutic uses thereof
12/06/2005CA2347512C Adenine derivatives
12/06/2005CA2325282C Use of apo b secretion/mtp inhibitors
12/06/2005CA2303537C Solid oral dosage form comprising a combination of metformin and glibenclamide
12/06/2005CA2289599C Substituted heterocyclic compounds, method for preparing and compositions containing same
12/06/2005CA2208274C Peptide p277 analogs, and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes
12/01/2005WO2005113499A1 Indole compounds
12/01/2005WO2005112949A1 Use of drug combinations for treating insulin resistance
12/01/2005WO2005112944A1 Drug for prevention or treatment of diabetes
12/01/2005WO2005112904A1 Peroxisome proliferator-activated receptor (ppar) activator and drugs, supplements, functional foods and food additives using the same
12/01/2005WO2005090301B1 Crystalline form of atorvastatin hemi calcium
12/01/2005WO2004080964A8 Indole derivatives useful for the treatment of diseases
12/01/2005US20050267205 2,4-dihydroxybenzoic acid derivatives
12/01/2005US20050267200 Heteroaromate OSC inhibitors
12/01/2005US20050267198 Novel processes for preparing amorphous atorvastatin hemi-calcium
12/01/2005US20050267195 Drug composition for blood sugar control
12/01/2005US20050267190 Solid-state form of celecoxib having enhanced bioavailability
12/01/2005US20050267189 Celecoxib compositions
12/01/2005US20050267185 1,2,4-triazole derivatives, compositions, process of making and methods of use
12/01/2005US20050267183 Selective estrogen receptor modulators
12/01/2005US20050267180 treatment/prevention of non-insulin dependent diabetes mellitus, lowing cholesterol, decrease blood pressure, counteract inflammatory atherosclerosis, metabolic disorders, polycystic ovary syndrome, liver disorders; S)-2-Ethoxy-3-[2-methyl-4-(5-methyl-2-o-tolyl-oxazol-4-ylmethoxy)-phenyl]-propionic acid
12/01/2005US20050267162 Hydrochloride salts of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
12/01/2005US20050267149 Benzoic acid derivatives as modulators of ppar alpha and gamma
12/01/2005US20050267147 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
12/01/2005US20050267137 Cyclopropane CGRP antagonists, medicaments containing these compounds, and method for the production thereof
12/01/2005US20050267133 Pyrazolopyrimidines as kinase inhibitors
12/01/2005US20050267129 Dipeptide nitrile cathepsin K inhibitors
12/01/2005US20050267118 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
12/01/2005US20050267114 Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient
12/01/2005US20050267049 Anti-hypercholesterolemic compounds
12/01/2005US20050267038 Novel diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
12/01/2005US20050266533 Therapeutic fusion protein with enhanced for use in prevention and treatment of cell proliferative, blood and nervous system disorders
12/01/2005US20050266532 Albumin fusion proteins
12/01/2005US20050266485 polynucleotides encoding a hematopoietic cytokine receptor polypeptide, for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs; test detecting a genetic disorder, cancer
12/01/2005US20050266065 Hydrated lamellar phases or liposomes which contain a fatty monoamine or a cationic polymer which promotes intracellular penetration, and a cosmetic or pharmaceutical composition containing same, as well as a method of screening such a substance
12/01/2005US20050265976 Method of differentiation of morula or inner cell mass cells and method of making lineage-defective embryonic stem cells
12/01/2005CA2824701A1 Modulation of glucose-6-phosphate translocase expression
12/01/2005CA2567854A1 Dpp-iv inhibitors
12/01/2005CA2567298A1 Methods and related compositions for reduction of fat
12/01/2005CA2566923A1 2-((hetero) aryl)-benzoxazole compounds and derivatives, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
12/01/2005CA2566873A1 Use of drug combinations for treating insulin resistance
12/01/2005CA2565300A1 Fgf-21 fusion proteins
12/01/2005CA2565029A1 Immediate release pharmaceutical tablets with height greater than width
11/2005
11/30/2005EP1600507A1 Cis-element regulating transcription, transcriptional regulatory factor binding specifically thereto and use of the same
11/30/2005EP1600445A1 Medicinal composition
11/30/2005EP1600442A1 Heteroarylcarbamoylbenzene derivative
11/30/2005EP1600162A1 Shelf-stable formulation of glucagon-like peptide-1
11/30/2005EP1599482A1 Pyrazolo 1,5-a pyrimidine derivatives
11/30/2005EP1599480A1 Substituted hexahydropyrazino(1,2-a)pyrimidin-4,7-dion derivatives, method for the production and use thereof as medicaments
11/30/2005EP1599477A1 Sulfonamide substituted xanthine derivatives for use as pepck inhibitors
11/30/2005EP1599468A1 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
11/30/2005EP1599464A2 Novel cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors
11/30/2005EP1599455A1 4-(3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexyloxy)-butane acid derivatives and related compounds as ppar modulators for treating diabetes of type 2 and atherosclerosis
11/30/2005EP1599454A2 Diarylcycloalkyl derivatives, method for their production and their use as medicaments
11/30/2005EP1599453A1 3-methyl-2- (3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexanecarbonyl-amino butyric acid derivatives and related compounds as ppar modulators for the treatment of type 2 diabetes and atherosclerosis
11/30/2005EP1599452A1 3-(2-phenyl-oxazol-4-yl methoxy) cyclohexylmethoxy acetic acid derivatives and related compounds used as ppar modulators for treating type 2 diabetes and arteriosclerosis
11/30/2005EP1599443A1 Cycloalkyl-substituted alkanoic acid derivatives, methods for the production thereof, and use thereof as a medicament
11/30/2005EP1599215A1 Use of tryptophan rich peptides
11/30/2005EP1599203A1 1,3-substituted cycloalkyl derivatives containing acidic, mainly heterocyclic groups, corresponding production method and use of said derivatives as medicaments
11/30/2005EP1599198A1 Potassium taurate bicarbonate and ascorbate complexes
11/30/2005EP1599167A2 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
11/30/2005EP1551431A4 Purified amylase inhibitor and novel process for obtaining the same
11/30/2005EP1467996B1 Pyrimidotriazines as phosphatase inhibitors
11/30/2005EP1461440A4 Cultured cells from pancreatic islets
1 ... 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 ... 1298